Induction of hepatitis e virus anti-orf3 antibodies from systemic administration of a muscle-specific adeno-associated virus (aav) vector

HIGHLIGHTS

• who: Lars Maurer and colleagues from the Schaller Research Group, Department of Infectious Diseases, Virology, University Hospital Heidelberg, German Center for Infection Research (DZIF), External Partner Site Bochum, Bochum, Germany have published the article: Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector, in the Journal: Viruses 2022, 14, x FOR PEER REVIEW of /2022/
• what: The authors explored systemic in vivo administration of a novel synthetic and myotropic Adeno-associated (AAVMYO3) to express the small phosphoprotein (found on quasi-enveloped in the musculature . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.